Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs
{{output}}
Background: Optimal outcome of treatment in rheumatoid arthritis (RA) is early clinical remission to delay joint damage. Therefore, severe RA patients with inadequate response to conventional disease modifying anti-rheumatic drug... ...
